- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04183647
Investigation of Acute Effects of Local Vibration and Whole-Body Vibration Applications
Investigation of Acute Effects of Local Vibration and Whole-Body Vibration Applications on Postural Control in Adult Patients With Ataxia
This study was designed as a single-blind, randomized and cross-over study to investigate and compare the acute effects of local vibration (LV) and whole-body vibration (WBV) applications on postural control in adult patients with ataxia.
The study will be included in patients aged 18-50 years, including ataxia diagnosed by the neurologist and able to walk independently. Patients with pregnancy status, epilepsy, spasticity, implant / endoprosthesis / pacemaker, benign paroxysmal positional vertigo, history of fracture in the last 6 months and other neurological diseases other than ataxia will not be included in the study. Between the applications, a washout period of one week will be given to each patient to apply both local and whole body vibrations. The order of application will be decided by the coin toss randomization method. Descriptive evaluations of the patients will be done with Mini-BESTest and Trunk Impairment Scale. Stability limits and postural sways (Bertec Balance Check ScreenerTM), gait time - distance characteristics (GAITRite), functional mobility skills (Timed Up and Go Test), and static balances (One Leg Stance Test) before, 1 minute after the application and 60 minutes after the application.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06100
- Hacettepe University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Located in the 18-50 age range, diagnosed with ataxia by the neurologist, patients who can walk independently
Exclusion Criteria:
- Patients with pregnancy status, epilepsy, spasticity, implant / endoprosthesis / pacemaker, benign paroxysmal positional vertigo, history of fracture in the last 6 months, and other neurological disorders other than ataxia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Local Vibration / Whole body vibration
Local vibration will be sequentially applied to the bilateral gastrosoleus complex with the Vibrasens © device. Application, the largest part of the muscle, each limb 5'er for a total of 10 minutes, static semi-squat position will be done. The vibration frequency is 80 Hz and the amplitude is 1 mm. |
Both the whole-body vibration application and the local vibration application will be applied to the patients in our cross-over study.
Between the two applications will be given a washout period of one week.
Patients will be evaluated both local and whole body vibration applications, 1 minute and 60 minutes after the end of the applications.
After the evaluation, the patient will be rested in the sitting position until the evaluation at the 60th minute.
|
|
ACTIVE_COMPARATOR: Whole body vibration/local vibration
Whole body vibration application will be done with Compex® Winplate device.
During this application, patients will be asked to continue static semi-squat position with 5 minutes of vibration and then 5 minutes of vibration.Vibration frequency, 30 Hz amplitude will be selected 2 mm.
|
Both the whole-body vibration application and the local vibration application will be applied to the patients in our cross-over study.
Between the two applications will be given a washout period of one week.
Patients will be evaluated both local and whole body vibration applications, 1 minute and 60 minutes after the end of the applications.
After the evaluation, the patient will be rested in the sitting position until the evaluation at the 60th minute.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mini-BESTest
Time Frame: The application will be made immediately after the evaluations are completed within the same day (on average 45 min before application).
|
It will be used for performance-oriented balance assessment.
The test consists of 14 items and is evaluated on a score of 0-2.
In the test, "0" indicates the lowest function level and "2 en indicates the highest function level.
|
The application will be made immediately after the evaluations are completed within the same day (on average 45 min before application).
|
|
Trunk Impairment Scale
Time Frame: The application will be made immediately after the evaluations are completed within the same day (on average 30 min before application).
|
It will be used to evaluate trunk control.
The scale has 17 items, 3 of which are static balance 10 are dynamic balance, 4 are stabilizer muscles.
The total score that can be obtained is minimum "0 minimum and maximum" 23..
|
The application will be made immediately after the evaluations are completed within the same day (on average 30 min before application).
|
|
Limits of Stability and Postural Sways
Time Frame: change from baseline at 1 min and 60 min after applications.
|
Bertec Balance Check Screener (Model BP5050) force platform system will be used.
This force platform will measure stability limits in 4 directions (anterior, posterior, right, left) and postural sways in 4 different conditions (firm surface -eyes open, firm surface-eyes closed, foam surface-eyes open, foam surface-eyes closed).
|
change from baseline at 1 min and 60 min after applications.
|
|
Time-Distance Characteristics of the Gait
Time Frame: change from baseline at 1 min and 60 min after applications.
|
GAITRite (CIR System INC. Clifton, NJ 07012) walkway system will be used.
GAITRite; It is an electronic walkway which consists of portable carpet and sensors embedded on the carpet and transfers every foot contact to the computer when individuals walk on the carpet.
With GAITRite, base of support (cm), velocity (cm / s) and cadence (steps / min) parameters will be evaluated.
|
change from baseline at 1 min and 60 min after applications.
|
|
Timed Up and Go Test
Time Frame: change from baseline at 1 min and 60 min after applications.
|
It will be used to evaluate functional mobility.
|
change from baseline at 1 min and 60 min after applications.
|
|
One Leg Stance Test
Time Frame: change from baseline at 1 min and 60 min after applications.
|
It will be used to evaluate static balance.
For the right and left lower extremities, eyes will be opened and closed in two ways.
|
change from baseline at 1 min and 60 min after applications.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Muhammed KILINÇ, Hacettepe University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Vibration Applications
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ataxia
-
Cadent TherapeuticsWithdrawnSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8 | Spinocerebellar Ataxia Type 17 | ARCA1 - Autosomal Recessive...United States
-
Assistance Publique - Hôpitaux de ParisCompletedSpinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia, Autosomal Recessive 3 | Episodic Ataxia, Type 7France
-
Haute Ecole de Santé VaudNot yet recruitingAtaxia | Ataxia, Spinocerebellar | Ataxia, Cerebellar | Ataxia - Other | Ataxia, Motor | Ataxias, Hereditary | Ataxia, Gait
-
Biohaven Pharmaceuticals, Inc.CompletedSpinocerebellar Ataxias | Spinocerebellar Ataxia Genotype Type 1 | Spinocerebellar Ataxia Genotype Type 2 | Spinocerebellar Ataxia Genotype Type 3 | Spinocerebellar Ataxia Genotype Type 6 | Spinocerebellar Ataxia Genotype Type 7 | Spinocerebellar Ataxia Genotype Type 8 | Spinocerebellar Ataxia Genotype...United States
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8United States, China
-
Teachers College, Columbia UniversityActive, not recruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 7United States
-
University of ChicagoPfizer; Biogen; APDM Wearable TechnologiesCompletedSpinocerebellar Ataxia Type 3 | Friedreich Ataxia | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6United States
-
University of FloridaUniversity of California, Los Angeles; National Ataxia FoundationRecruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6United States
-
University Health Network, TorontoRecruiting
-
IRCCS Eugenio MedeaRecruiting
Clinical Trials on whole body vibration / local vibration
-
University of North Carolina, Chapel HillUnited States Department of DefenseCompletedVibratory Stimuli, A Novel Rehabilitation Method for Preventing Post - Traumatic Knee OsteoarthritisKnee OsteoarthritisUnited States
-
Taipei Medical UniversityTaipei Medical University WanFang HospitalRecruitingCOPD | Vibration Therapy | COPD Chronic Obstructive Pulmonary DiseaseTaiwan
-
The Hong Kong Polytechnic UniversityCompleted
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Gazi UniversityGulhane Training and Research HospitalCompletedArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
The Hong Kong Polytechnic UniversityUnknown
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States
-
University of the Balearic IslandsUnknown
-
Cairo UniversityRecruitingOverweight , ObesitySaudi Arabia